SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners’s $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for Shareholders
The firm is also examining whether the proxy statement will leave out material information Surgery Partners
